Compare PRSO & BFRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRSO | BFRG |
|---|---|---|
| Founded | 2008 | 2017 |
| Country | United States | United States |
| Employees | N/A | 17 |
| Industry | Semiconductors | Retail: Computer Software & Peripheral Equipment |
| Sector | Technology | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.8M | 6.9M |
| IPO Year | 2000 | N/A |
| Metric | PRSO | BFRG |
|---|---|---|
| Price | $0.96 | $0.51 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $3.00 | N/A |
| AVG Volume (30 Days) | ★ 13.4M | 131.1K |
| Earning Date | 03-16-2026 | 03-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 86.27 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $14,573,000.00 | N/A |
| Revenue This Year | $24.41 | N/A |
| Revenue Next Year | $32.45 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 5.99 | N/A |
| 52 Week Low | $0.52 | $0.43 |
| 52 Week High | $2.37 | $2.20 |
| Indicator | PRSO | BFRG |
|---|---|---|
| Relative Strength Index (RSI) | 43.83 | 37.99 |
| Support Level | $0.85 | $0.43 |
| Resistance Level | $1.04 | $0.69 |
| Average True Range (ATR) | 0.15 | 0.06 |
| MACD | -0.06 | -0.01 |
| Stochastic Oscillator | 2.57 | 13.99 |
Peraso Inc is a fabless semiconductor company focused on the development and sale of: i) millimeter wavelength wireless technology, or mmWave, semiconductor devices and antenna modules based on its proprietary semiconductor devices and ii) performance of non-recurring engineering, or NRE, services and licensing of intellectual property, or IP. The company's primary focus is the development of mmWave, which is generally described as the frequency band from 24 Gigahertz, or GHz, to 300 GHz. Geographically the company generates revenue from the United States, Hong Kong, Taiwan, and the Rest of the World.
Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects. Its platform technology, named, bfLEAP, is an analytical AI/ML platform that is able to surmount the challenges of scalability and flexibility currently hindering researchers and clinicians by providing a more precise1, multi-dimensional understanding of its data.